TY - JOUR
T1 - Gene expression profiles of bronchoalveolar cells in pulmonary TB
AU - Raju, Bindu
AU - Hoshino, Yoshihiko
AU - Belitskaya-Lévy, Ilana
AU - Dawson, Rod
AU - Ress, Stanley
AU - Gold, Jeffrey A.
AU - Condos, Rany
AU - Pine, Richard
AU - Brown, Stuart
AU - Nolan, Anna
AU - Rom, William N.
AU - Weiden, Michael D.
N1 - Funding Information:
Funding: This work was supported by NIH/NCRR Grants M01 RR00096 and HL-59832, HL-57879, HL-68517, NYC Speakers Award to BR, and Uehara Memorial Foundation Award to YH.
PY - 2008/1
Y1 - 2008/1
N2 - The host response to Mycobacterium tuberculosis includes macrophage activation, inflammation with increased immune effector cells, tissue necrosis, and cavity formation, and fibrosis, distortion, and bronchiectasis. To evaluate the molecular basis of the immune response in the lungs of patients with active pulmonary tuberculosis (TB), we used bronchoalveolar lavage to obtain cells at the site of infection. Affymetrix GeneChip microarrays and cDNA nylon filter microarrays interrogated gene expression in bronchoalveolar lavage (BAL) cells from 11 healthy controls and 17 patients with active pulmonary TB. We found altered gene expression for 69 genes in TB versus normal controls that included cell surface markers, cytokines, chemokines, receptors, transcription factors, and complement components. In addition, TB BAL cell gene expression patterns segregated into 2 groups: one suggestive of a T helper type 1 (Th1) cellular immune response with increased signal transducer and activator of transcription-4 (STAT-4), interferon-gamma (IFN-γ receptor), and monokine induced by IFN-γ (MIG) expression with increased IFN-γ protein levels in BAL fluid; the other group displayed characteristics of Th2 immunity with increased STAT-6, CD81, and IL-10 receptor expression. We were able to demonstrate that a Th2 presentation could change to a Th1 pattern after anti-tuberculous treatment in 1 TB patient studied serially. These gene expression data support the conclusion that pulmonary TB produces a global change in the BAL cell transcriptome with manifestations of either Th1 or Th2 immunity.
AB - The host response to Mycobacterium tuberculosis includes macrophage activation, inflammation with increased immune effector cells, tissue necrosis, and cavity formation, and fibrosis, distortion, and bronchiectasis. To evaluate the molecular basis of the immune response in the lungs of patients with active pulmonary tuberculosis (TB), we used bronchoalveolar lavage to obtain cells at the site of infection. Affymetrix GeneChip microarrays and cDNA nylon filter microarrays interrogated gene expression in bronchoalveolar lavage (BAL) cells from 11 healthy controls and 17 patients with active pulmonary TB. We found altered gene expression for 69 genes in TB versus normal controls that included cell surface markers, cytokines, chemokines, receptors, transcription factors, and complement components. In addition, TB BAL cell gene expression patterns segregated into 2 groups: one suggestive of a T helper type 1 (Th1) cellular immune response with increased signal transducer and activator of transcription-4 (STAT-4), interferon-gamma (IFN-γ receptor), and monokine induced by IFN-γ (MIG) expression with increased IFN-γ protein levels in BAL fluid; the other group displayed characteristics of Th2 immunity with increased STAT-6, CD81, and IL-10 receptor expression. We were able to demonstrate that a Th2 presentation could change to a Th1 pattern after anti-tuberculous treatment in 1 TB patient studied serially. These gene expression data support the conclusion that pulmonary TB produces a global change in the BAL cell transcriptome with manifestations of either Th1 or Th2 immunity.
KW - Bronchoalveolar lavage
KW - Functional genomics
KW - Human
KW - Immunity
KW - Tuberculosis
UR - http://www.scopus.com/inward/record.url?scp=37249034633&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=37249034633&partnerID=8YFLogxK
U2 - 10.1016/j.tube.2007.07.003
DO - 10.1016/j.tube.2007.07.003
M3 - Article
C2 - 17921069
AN - SCOPUS:37249034633
SN - 1472-9792
VL - 88
SP - 39
EP - 51
JO - Tuberculosis
JF - Tuberculosis
IS - 1
ER -